TY - JOUR
T1 - alpha-Dystroglycan hypoglycosylation affects cell migration by influencing beta-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis
AU - Palmieri, V.
AU - Bozzi, Manuela
AU - Signorino, G.
AU - Papi, Massimiliano
AU - De Spirito, Marco
AU - Brancaccio, A.
AU - Maulucci, Giuseppe
AU - Sciandra, F.
PY - 2017
Y1 - 2017
N2 - Dystroglycan (DG) serves as an adhesion complex linking the actin cytoskeleton to the extracellular matrix. DG is encoded by a single gene as a precursor, which is constitutively cleaved to form the α- and β-DG subunits. α-DG is a peripheral protein characterized by an extensive glycosylation that is essential to bind laminin and other extracellular matrix proteins, while β-DG binds the cytoskeleton proteins. The functional properties of DG depend on the correct glycosylation of α-DG and on the cross-talk between the two subunits. A reduction of α-DG glycosylation has been observed in muscular dystrophy and cancer while the inhibition of the interaction between α- and β-DG is associated to aberrant post-translational processing of the complex. Here we used confocal microscopy based techniques to get insights into the influence of α-DG glycosylation on the functional properties of the β-DG, and its effects on cell migration. We used epithelial cells transfected with wild-type and with a mutated DG harboring the mutation T190 M that has been recently associated to dystroglycanopathy. We found that α-DG hypoglycosylation, together with an increased protein instability, reduces the membrane dynamics of the β-subunit and its clustering within the actin-rich domains, influencing cell migration and spontaneous cell movement. These results contribute to give novel insights into the involvement of aberrant glycosylation of DG in the developing of muscular dystrophy and tumor metastasis.
AB - Dystroglycan (DG) serves as an adhesion complex linking the actin cytoskeleton to the extracellular matrix. DG is encoded by a single gene as a precursor, which is constitutively cleaved to form the α- and β-DG subunits. α-DG is a peripheral protein characterized by an extensive glycosylation that is essential to bind laminin and other extracellular matrix proteins, while β-DG binds the cytoskeleton proteins. The functional properties of DG depend on the correct glycosylation of α-DG and on the cross-talk between the two subunits. A reduction of α-DG glycosylation has been observed in muscular dystrophy and cancer while the inhibition of the interaction between α- and β-DG is associated to aberrant post-translational processing of the complex. Here we used confocal microscopy based techniques to get insights into the influence of α-DG glycosylation on the functional properties of the β-DG, and its effects on cell migration. We used epithelial cells transfected with wild-type and with a mutated DG harboring the mutation T190 M that has been recently associated to dystroglycanopathy. We found that α-DG hypoglycosylation, together with an increased protein instability, reduces the membrane dynamics of the β-subunit and its clustering within the actin-rich domains, influencing cell migration and spontaneous cell movement. These results contribute to give novel insights into the involvement of aberrant glycosylation of DG in the developing of muscular dystrophy and tumor metastasis.
KW - Confocal microscopy
KW - Cytoskeleton
KW - Dystroglycan
KW - Dystroglycanopathies
KW - Extracellular matrix
KW - Fluorescence recovery after photobleaching
KW - Glycosylation
KW - Molecular Biology
KW - Molecular Medicine
KW - Confocal microscopy
KW - Cytoskeleton
KW - Dystroglycan
KW - Dystroglycanopathies
KW - Extracellular matrix
KW - Fluorescence recovery after photobleaching
KW - Glycosylation
KW - Molecular Biology
KW - Molecular Medicine
UR - https://publicatt.unicatt.it/handle/10807/108396
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85021236490&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85021236490&origin=inward
U2 - 10.1016/j.bbadis.2017.05.025
DO - 10.1016/j.bbadis.2017.05.025
M3 - Article
SN - 0925-4439
VL - 1863
SP - 2182
EP - 2191
JO - Biochimica et Biophysica Acta - Molecular Basis of Disease
JF - Biochimica et Biophysica Acta - Molecular Basis of Disease
IS - 9
ER -